Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Treatment Clinical Trials for Soft Tissue Sarcoma

Review the soft tissue sarcoma treatment clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 101-122 of 122

Spatially Fractionated GRID Radiation Therapy for the Treatment of Soft Tissue Sarcoma in Patients Undergoing Standard Radiation Therapy and Surgery
Status: Active
Location: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
Consolidative Radiation Therapy for the Treatment of Pediatric and Young Adult Patients with Metastatic or Progressive Soft Tissue or Bone Sarcoma, Target-RT Trial
Status: Active
Location: Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland
A Study Comparing the Efficacy of L19TNF+Doxorubicin vs Doxorubicin Alone as First-line Therapy in Patients With Advanced or Metastatic Soft Tissue Sarcoma
Status: Active
Location: See ClinicalTrials.gov
A Study of sEphB4-HSA in Kaposi Sarcoma
Status: Active
Location: UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas
Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma
Status: Active
Location: See ClinicalTrials.gov
Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors
Status: Active
Location: See ClinicalTrials.gov
A Study Evaluating MM-310 in Patients With Solid Tumors
Status: Active
Location: See ClinicalTrials.gov
A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
Status: Active
Location: Mayo Clinic in Florida, Jacksonville, Florida
PM14 Administered Intravenously to Patients with Advanced Solid Tumors
Status: Active
Location: See ClinicalTrials.gov
A Study of PSB205 in Subjects With Advanced Solid Tumors
Status: Active
Location: See ClinicalTrials.gov
Pomalidomide and Nivolumab for the Treatment of Virus-Associated Malignancies with or without HIV
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
A Study of BND-35 in Participants With Advanced Solid Tumors
Status: Active
Location: University of Colorado, Denver, Colorado
Paclitaxel or Liposomal Doxorubicin for HIV-positive Persons with Kaposi Sarcoma
Status: Approved
Location: Location information is not yet available.
Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed with Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body
Status: Approved
Location: Location information is not yet available.
Zanzalintinib in Combination with Ipilimumab and Nivolumab for the Treatment of Metastatic or Unresectable Refractory Soft Tissue Sarcoma
Status: Approved
Location: Siteman Cancer Center at Washington University, Saint Louis, Missouri
Shorter Course, Hypofractionated Pre-Surgery Radiation Therapy in Treating Patients with Localized, Resectable Soft Tissue Sarcoma of the Extremity of Superficial Trunk
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas
Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas
Atezolizumab in Combination with Cyclophosphamide, Sorafenib, and Bevacizumab for the Treatment of Recurrent or Refractory Solid Tumors in Pediatric Patients, ANGIO-A Study
Status: Temporarily Closed to Accrual
Location: Saint Jude Children's Research Hospital, Memphis, Tennessee
Gemcitabine and Docetaxel with Radiation Therapy before Surgery for the Treatment of High Grade and Greater than 5 cm Soft Tissue Sarcoma of the Extremities
Status: Temporarily Closed to Accrual
Location: Wake Forest University Health Sciences, Winston-Salem, North Carolina
Targeted IL12 T-cell Therapy for Treatment Advanced or Metastatic Soft Tissue or Bone Sarcomas
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas
Bevacizumab and Temsirolimus Alone or in Combination with Valproic Acid or Cetuximab in Treating Patients with Advanced or Metastatic Malignancy or Other Benign Disease
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas
DNX-2440 for Resectable Colorectal Liver Metastasis
Status: Temporarily Closed to Accrual
Location: See ClinicalTrials.gov